MaxLinear, Inc. (NYSE:MXL) acquired NanoSemi, Inc. for $96.8 million on September 9, 2020. The consideration for the transaction consisted of $10 million in cash and 0.8 million shares of MaxLinear’s common stock. In addition, the securityholders of NanoSemi will receive $35 million in deferred cash payments payable in 2021, and the NanoSemi securityholders may also receive up to an additional $35 million in potential earnout consideration, subject to NanoSemi satisfying certain financial objectives from July 1, 2020 through December 31, 2022. The team of NanoSemi will join MaxLinear. Wilson Sonsini Goodrich & Rosati acted as a financial advisor to MaxLinear, Inc. in the deal. MaxLinear, Inc. (NYSE:MXL) completed the acquisition of NanoSemi, Inc. on September 9, 2020. As a part of acquisition, MaxLinear agreed to provide the NanoSemi stockholders with certain registration rights with respect to the shares of MaxLinear common stock they received in the acquisition. As of March 31, 2021, the Company has made $20 million of $35 million in deferred cash payments.